Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine.
This article reviews the advances in neurosurgery, neuroradiology, and neuroendocrinology that have altered the management of patients with pituitary adenomas. These benign tumors can produce significant morbidity including loss of vision. Morbidity may be avoided or corrected if available diagnostic and therapeutic options are instituted appropriately.
D000236:Adenoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008866:Microsurgery; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D013101:Sphenoid Sinus / Q000601:surgery; D014057:Tomography, X-Ray Computed
D001971:Bromocriptine; D011388:Prolactin